Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors for Treatment of Anemia in Chronic Kidney Disease: Guidelines for South Asia.
South Asia HIF-PHI for Anemia in CKD Guideline Development Group; Abraham A, Almeida A, Bhalla AK, Chaudury AR, Dutta AR, Gupta A, Shah B, Roy B, Subbarao B, Herath C, Amrutha C, Shah DS, Pahari DK, Khullar D, Bajpai D, Simaladinne GV, Kothari J, Tyagi J, Sharma I, Shah K, Malik M, Sahay M, Sharma M, Gumber M, Sreelatha M, Tiwaskar M, Kaur M, Alam MR, Gopalakrishnan N, Prasad N, Kamath N, Meena P, Varma PP, Das P, Ramachandran R, Sharma RK, George R, Jain S, Ingale S, Moola S, Bhattacharya SK, D'Cruz S, Gulati S, Saxena S, Sundar S, Acharya S, Bansal SB, Vishwanath S, Gang S, Raju SB, Parameswaran S, Bhaumik S, Madhu SV, Alexander S, Jeloka T, Saha TK, Das T, Anandh U, Khanna U, Bhatia V, Saxena V, Kher V, Raghavan V, Jha V; *Steering Committee†; Methodology Committee (non-voting)#; Guideline Development Panel$.
South Asia HIF-PHI for Anemia in CKD Guideline Development Group, et al. Among authors: gopalakrishnan n.
Indian J Nephrol. 2025 Mar-Apr;35(2):129-167. doi: 10.25259/ijn_389_23. Epub 2025 Feb 25.
Indian J Nephrol. 2025.
PMID: 40060060
Free PMC article.